B. Braun CARESITE Port Access Kit w/Tegaderm, REF 375214, Central Venous (cardiac) Catheter Tray ...

FDA Device Recall #Z-0265-2023 — Class II — September 15, 2022

Recall Summary

Recall Number Z-0265-2023
Classification Class II — Moderate risk
Date Initiated September 15, 2022
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Medical Action Industries, Inc. 306
Location Arden, NC
Product Type Devices
Quantity 240 cases of 20 units

Product Description

B. Braun CARESITE Port Access Kit w/Tegaderm, REF 375214, Central Venous (cardiac) Catheter Tray (REF number corrected 11/23/2022)

Reason for Recall

The kits were incorrectly labeled with an extended expiration date of 02/21/2024 instead of 02/10/2024.

Distribution Pattern

US Nationwide distribution in the state of Pennsylvania.

Lot / Code Information

UDI/DI 10809160283875, Batch/Lot number 298442

Other Recalls from Medical Action Industries, Inc. 306

Recall # Classification Product Date
Z-3129-2024 Class II Foam Protective Pouches, model numbers 6010 (50... Jun 11, 2024
Z-1394-2024 Class II IV Start Kit, containing 1 Saline Syringe 5ml, ... Jan 15, 2024
Z-0751-2023 Class II Medical Action INDUSTRIES INC. Port a Cath Kit ... Nov 4, 2022
Z-0464-2023 Class II Medical Action Industries Inc. Port Access Kit,... Oct 12, 2022
Z-0765-2023 Class II Medical Action Industries Inc. Disposable Instr... Oct 12, 2022

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.